Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Explore the differences between zero based and traditional budgeting to find the best fit for your financial needs. Make your budgeting work for you.
19,711 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Ready to retire sooner with rental properties? This guide shows you how to build your 2026 plan with smart loan choic...
Two lesser-known robotics stocks beat earnings, underscoring a broader wave of AI-powered automation beyond the famil...
A potential shift toward a friendlier regulatory environment horizon may change the energy investing landscape. This ...
Strategy (formerly MicroStrategy) appears poised to complete its 100th Bitcoin purchase, signaling a bold continuatio...
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
A record blizzard shut down The Boston Globe's print operations for the first time in 153 years. Tuesday's edition wi...
Investors are watching Micron Technology closely as AI-driven demand reshapes memory markets. This guide explains whe...
A fresh look at how large holders deploy a bitcoin giant strategy and why Coinbase finds itself among the most shorte...
A veteran macro strategist says the classic college route may not pay off for today’s youth. He points to skilled tra...
Bitcoin rebounded toward $69,000 after a volatile session that dumped price into the low $60,000s and rattled traders...
A heartfelt tribute to a TV icon offers more than nostalgia. It can spark practical money moves—funeral budgeting, es...